|
gptkbp:instanceOf
|
gptkb:medical_condition
gptkb:disease
|
|
gptkbp:affects
|
gptkb:adipose_tissue
|
|
gptkbp:associatedWith
|
HIV infection
CGL1
CGL2
LMNA gene mutation
PPARG gene mutation
|
|
gptkbp:causedBy
|
gptkb:antiretroviral_therapy
gptkb:autoimmune_disease
gptkb:genetic_disorder
|
|
gptkbp:class
|
gptkb:rare_disease
|
|
gptkbp:complication
|
gptkb:liver_disease
gptkb:polycystic_ovary_syndrome
gptkb:cardiomyopathy
pancreatitis
|
|
gptkbp:firstDescribed
|
1920s
|
|
gptkbp:hasOrphanetID
|
ORPHA:199
|
|
gptkbp:ICD-10_code
|
E88.1
|
|
gptkbp:inheritance
|
autosomal dominant
autosomal recessive
|
|
gptkbp:MeSH_ID
|
D008070
|
|
gptkbp:OMIM
|
151660
|
|
gptkbp:prevalence
|
very rare
|
|
gptkbp:riskFactor
|
autoimmune disorders
genetic predisposition
HIV treatment
|
|
gptkbp:studiedIn
|
genetics
endocrinology
metabolism research
|
|
gptkbp:subspecies
|
gptkb:familial_partial_lipodystrophy
gptkb:congenital_generalized_lipodystrophy
acquired generalized lipodystrophy
acquired partial lipodystrophy
|
|
gptkbp:symptom
|
gptkb:diabetes_mellitus
insulin resistance
hypertriglyceridemia
hepatic steatosis
abnormal fat distribution
|
|
gptkbp:synonym
|
lipoatrophy
fat redistribution syndrome
|
|
gptkbp:treatment
|
gptkb:physician
gptkb:insulin
gptkb:metreleptin
diet modification
lipid-lowering agents
|
|
gptkbp:bfsParent
|
gptkb:P51608
gptkb:DB00005
gptkb:P28562
|
|
gptkbp:bfsLayer
|
8
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Lipodystrophy
|